Raspollini et al. [60] studied the expression of iNOS (immunohistochemistry assay) in specimens obtained by surgical resection from 78 patients with stage III (FIGO classification) ovarian serous carcinoma with a low grade of differentiation (G3). The gene discussed is NOS2; the disease is ovarian serous carcinoma.